ATE276761T1 - Vorbeugung von typ-1 diabetes und anderen nicht- polio enteroviren - Google Patents
Vorbeugung von typ-1 diabetes und anderen nicht- polio enterovirenInfo
- Publication number
- ATE276761T1 ATE276761T1 AT00912706T AT00912706T ATE276761T1 AT E276761 T1 ATE276761 T1 AT E276761T1 AT 00912706 T AT00912706 T AT 00912706T AT 00912706 T AT00912706 T AT 00912706T AT E276761 T1 ATE276761 T1 AT E276761T1
- Authority
- AT
- Austria
- Prior art keywords
- type
- opv
- killed
- polio
- prevention
- Prior art date
Links
- 241000709661 Enterovirus Species 0.000 title abstract 4
- 208000000474 Poliomyelitis Diseases 0.000 title abstract 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 2
- 230000004044 response Effects 0.000 abstract 2
- 229940124867 Poliovirus vaccine Drugs 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960005030 other vaccine in atc Drugs 0.000 abstract 1
- 229940031626 subunit vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14087299P | 1999-06-24 | 1999-06-24 | |
| PCT/FI2000/000220 WO2001000236A1 (en) | 1999-06-24 | 2000-03-17 | Prevention of type 1 diabetes and other non-polio enterovirus diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE276761T1 true ATE276761T1 (de) | 2004-10-15 |
Family
ID=22493179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00912706T ATE276761T1 (de) | 1999-06-24 | 2000-03-17 | Vorbeugung von typ-1 diabetes und anderen nicht- polio enteroviren |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1187631B1 (de) |
| AT (1) | ATE276761T1 (de) |
| AU (1) | AU770922B2 (de) |
| CA (1) | CA2376923C (de) |
| DE (1) | DE60014077T2 (de) |
| DK (1) | DK1187631T3 (de) |
| ES (1) | ES2228481T3 (de) |
| NO (1) | NO328680B1 (de) |
| PT (1) | PT1187631E (de) |
| WO (1) | WO2001000236A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8961982B2 (en) * | 2005-12-16 | 2015-02-24 | The Regents Of The University Of California | Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer |
| FI20075063A0 (fi) * | 2007-02-01 | 2007-02-01 | Vactech Oy | Allergisen herkistymisen estäminen |
| FI20075861A0 (fi) | 2007-11-30 | 2007-11-30 | Vactech Oy | Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä |
| US20110245179A1 (en) * | 2008-09-17 | 2011-10-06 | Woo Jin Park | Composition for Prevention or Treatment of Heart Failure |
| EP2402029A1 (de) | 2010-07-01 | 2012-01-04 | Sanofi Pasteur | Enterovirus-Impfstoffe zur Vorbeugung oder Behandlung von Typ-1-Diabetes (III) |
| EP2402027A1 (de) | 2010-07-01 | 2012-01-04 | Sanofi Pasteur | Enterovirus-Impfstoffe zur Vorbeugung oder Behandlung von Typ-1-Diabetes (I) |
| EP2588134B1 (de) | 2010-07-01 | 2016-10-26 | Vactech OY | Diagnostischer test für typ-1-diabetes |
| EP2402028A1 (de) | 2010-07-01 | 2012-01-04 | Sanofi Pasteur | Enterovirus-Impfstoffe zur Vorbeugung und Behandlung von Typ-1-Diabetes (II) |
| EP2583688A1 (de) | 2011-10-18 | 2013-04-24 | Sanofi Pasteur | Multi-CBV-Impfstoffe zur Vorbeugung oder Behandlung von Typ-1-Diabetes |
| DK2780067T3 (da) | 2011-11-18 | 2021-08-16 | Colin Dunlop | Anæstetisk genåndingskredsløb |
| US20140271718A1 (en) | 2013-03-15 | 2014-09-18 | University Of Florida Research Foundation Incorporated | Novel type 1 diabetes vaccines, and methods of use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5728385A (en) * | 1993-08-12 | 1998-03-17 | Classen Immunotherapies, Inc. | Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
-
2000
- 2000-03-17 ES ES00912706T patent/ES2228481T3/es not_active Expired - Lifetime
- 2000-03-17 DE DE60014077T patent/DE60014077T2/de not_active Expired - Lifetime
- 2000-03-17 WO PCT/FI2000/000220 patent/WO2001000236A1/en not_active Ceased
- 2000-03-17 DK DK00912706T patent/DK1187631T3/da active
- 2000-03-17 CA CA2376923A patent/CA2376923C/en not_active Expired - Fee Related
- 2000-03-17 EP EP00912706A patent/EP1187631B1/de not_active Expired - Lifetime
- 2000-03-17 AU AU34366/00A patent/AU770922B2/en not_active Ceased
- 2000-03-17 PT PT00912706T patent/PT1187631E/pt unknown
- 2000-03-17 AT AT00912706T patent/ATE276761T1/de active
-
2001
- 2001-12-18 NO NO20016211A patent/NO328680B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20016211D0 (no) | 2001-12-18 |
| AU770922B2 (en) | 2004-03-11 |
| NO328680B1 (no) | 2010-04-26 |
| DE60014077D1 (de) | 2004-10-28 |
| DE60014077T2 (de) | 2005-10-20 |
| WO2001000236A1 (en) | 2001-01-04 |
| ES2228481T3 (es) | 2005-04-16 |
| CA2376923A1 (en) | 2001-01-04 |
| EP1187631A1 (de) | 2002-03-20 |
| NO20016211L (no) | 2002-02-20 |
| CA2376923C (en) | 2014-08-05 |
| PT1187631E (pt) | 2005-01-31 |
| EP1187631B1 (de) | 2004-09-22 |
| AU3436600A (en) | 2001-01-31 |
| DK1187631T3 (da) | 2005-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0009267A (pt) | Tratamento da hepatite c com o uso da hipertermia | |
| MXPA02012443A (es) | Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos. | |
| ATE276761T1 (de) | Vorbeugung von typ-1 diabetes und anderen nicht- polio enteroviren | |
| BRPI0309631A2 (pt) | vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3,e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4 | |
| NO20090865L (no) | Vaksine | |
| EA200700243A1 (ru) | Способы лечения гепатита с | |
| WO2004060308A3 (en) | Thiosemicarbazones as anti-virals and immunopotentiators | |
| EA200201263A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ | |
| WO2007025043A3 (en) | Seven-membered ring nucleosides | |
| EA200700496A1 (ru) | Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита | |
| ATE19591T1 (de) | Virus der infektioesen katzen-bauchfellentzuendung, seine herstellung und es enthaltende vakzine. | |
| RU2004115107A (ru) | Способы профилактики и лечения инфекции, вызываемой флавивирусами у животных | |
| WO2001097824A3 (de) | Verwendung von phyllanthusbestandteilen zur behandlung oder prophylaxe von infekten durch flaviviridae | |
| MXPA03009763A (es) | Vacuna contra el virus de la enfermedad de la fiebre aftosa. | |
| UA103158C2 (ru) | Конъюгат белок-полимер и способ лечения с его помощью | |
| DK0383433T3 (da) | Svækkede vira | |
| ATE401392T1 (de) | Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion | |
| MX2007002659A (es) | Composicion vacunal contra el virus de la hepatitis c. | |
| BR0101523A (pt) | Pestivìrus, vacina, e, processos para imunizarcontra doença induzida por pestivìrus e parafabricar uma vacina para a proteção de um animalcontra um pestivìrus | |
| RU2002118650A (ru) | Штамм № 1737/Грузия/2000 вируса ящура типа Азия-1 для изготовления диагностических и вакцинных препаратов | |
| DK1132466T3 (da) | Kyllingeanæmivira med lav patogenicitet | |
| DE60222528D1 (de) | Impfstoff gegen Pferdearteritisvirus | |
| Centers for Disease Control and Prevention (CDC | Progress toward poliomyelitis eradication--Myanmar, 1996-1999 | |
| FI893346A0 (fi) | Icke-reverterande rna-virus. | |
| Centers for Disease Control and Prevention (CDC | Progress toward poliomyelitis eradication--Nigeria, January 2008-July 2009 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1187631 Country of ref document: EP |